Providing for consideration of the bill (H.R. 1862) to amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmaceuticals.

Hozzl · 2023-01-16T04:33:16Z

Explore the details of House Bill 517 Providing for consideration of the bill (H.R. 1862) to amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmaceuticals. currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Congress. Stay informed on legislative developments.

1/16/2023, 4:33 AM

Congressional Summary of HRES 517

Sets forth the rule (open) for the consideration of H.R. 1862 (greater access to affordable pharmaceuticals).

Read the Full Bill

Formatted Text PDF

Current Status of Bill HRES 517

Bill HRES 517 is currently in the status of Bill Introduced since September 5, 2002. Bill HRES 517 was introduced during Congress 107 and was introduced to the House on September 5, 2002. Bill HRES 517's most recent activity was Motion to Discharge Committee filed by Mrs. Thurman. Petition No: 107-11. (<a href="http://clerk.house.gov/107/lrc/pd/Petitions/Dis11.htm">Discharge petition</a> text with signatures.) as of September 19, 2002

Bipartisan Support of Bill HRES 517

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HRES 517

Primary Policy Focus

Congress

Potential Impact Areas

- Health

- House rules and procedure

Alternate Title(s) of Bill HRES 517

Providing for consideration of the bill (H.R. 1862) to amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmaceuticals.